FEMY Femasys Inc Cumulative Company Assets

Official company branding of Femasys Inc (FEMY)

This price chart for Femasys Inc. (FEMY) total assets, which reach 13.04, serves as confirmation of the market valuation and is based on the effective supply chain management of high-precision gynecological equipment. Femasys Inc. (FEMY) is implementing non-surgical methods for infertility determination and long-term contraception, aiming to simplify diagnostics in clinics. The business relies on stable demand, remaining independent of economic downturns thanks to successful clinical trials.

Company Total Assets: Femasys Inc (FEMY) for 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for Femasys Corp (FEMY)

- stock value and consensus price forecast:
Market Price femasys.com|FEMY - Price Target Chart
- market capitalization data:
Market Valuation Femasys Corporation|FEMY - Enterprise Value
- company book value details:
Net Asset Value per Share Femasys|FEMY - Book Capitalization|Capitalization to Book Value Ratio femasys.com|FEMY - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Femasys Inc.|FEMY - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Femasys Corporation|FEMY - Company Aggregate Debts|Debts to Book Capitalization Femasys Corporation|FEMY - Company Long-Term Debt|Company Short-Term Debt Femasys
Fundamental valuation:Femasys Inc.
Mass-produced product of Femasys Inc.

Femasys Inc. (FEMY) maintains a monopoly position in gynecological innovations, with its ownership of patents for the FemaSeed and FemBloc systems defining the structure of its resource base. By analyzing total asset trends calculated reverse-engineered through return on assets (ROA), investors can assess the aggregate volume of controlled assets and liabilities, providing insight into the efficiency of business scaling and capital management discipline.

Main competitors

Company Assets intuitive.com (ISRG)|Aggregate Company Assets Danaher|Cumulative Company Assets BD (BDX)|Company Total Assets STE|WST - Company Assets|Company Total Assets BAX (Baxter International)|MASI: Total Business Assets|Stevanato Group - Company Total Assets|Company Total Asset Base Teleflex Inc. TFX|MMSI: Company Total Assets|Cumulative Company Assets Nobel Biocare|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets dentsplysirona.com|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets ATRC (AtriCure Inc)|STAAR Surgical Corp - Cumulative Company Assets|Aggregate Asset Value NAGE|ZimVie Inc. - Company Total Assets|Company Total Asset Base angiodynamics.com ANGO|Cerus (CERS) - Aggregate Company Assets|Total Business Assets TKNO|Aggregate Company Assets Monogram Technologies Inc|Sharps Tech (STSS) - Company Total Asset Base|Cumulative Company Assets INFU (InfuSystem Holdings)|Aggregate Business Assets UTMD|Aggregate Company Assets KORU Medical KRMD|Aggregate Asset Value NYXH|MBOT: Cumulative Company Assets|PDEX - Company Total Assets|Zentek Ltd. (ZTEK) - Aggregate Company Assets|Cumulative Company Assets elutia.com|MLSS (Milestone Scientific Inc.) - Company Total Assets|Company Assets NEXGEL Inc. NXGL|Aggregate Company Assets Retractable Technologies (RVP)|harvardbioscience.com - Total Business Assets|Meihua Medical Technologies Co., Ltd. - Cumulative Company Assets|Aggregate Business Assets POAI (Predictive Oncology Inc)|CJMB - Aggregate Company Assets|Company Total Asset Base Atrion Corp. ATRI|NURO: Company Total Assets